Advertisements

Amyclox LB

Quick links to important sections

Amyclox LB

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amyclox LB

Property Description
Active ingredient Amoxicillin, Cloxacillin, Lactobacillus
Form Oral Capsule, Tablet, or Suspension
Pharmacological class Antibiotic and Probiotic combination
Common purpose Management of susceptible bacterial infections
Origin Semi-synthetic (Antibiotics) and Biological (Probiotic)

What Type of Combination Medicine is Amyclox LB?

Amyclox LB is recognized as a specific trade name for a fixed-dose triple combination product belonging to the Antibiotic and Probiotic combination class for the oral route of administration. The formulation integrates two beta-Lactam antibiotics (Amoxicillin and Cloxacillin) with a natural/biological probiotic (Lactobacillus). This combination is structurally similar to alternatives such as Symbiotik or Nodimox Plus LB, offering patients an established pharmaceutical composition. The antibiotic components, Amoxicillin and Cloxacillin, are both recognized as members of the Penicillins pharmacological group, a key class of antibacterials.

Amyclox LB Composition: Understanding the Active Ingredients and Form

The drug's core identity is defined by its three active ingredients: Amoxicillin, Cloxacillin, and Lactobacillus. Cloxacillin is included specifically because it is pharmacologically proven to target bacterial strains that possess resistance mechanisms against standard penicillins. This dual-antibiotic strategy is designed to enhance efficacy against a wider range of pathogens. The medicine is most frequently supplied as an oral capsule or tablet for ease of systemic delivery.

General Purpose: Why is Amoxicillin, Cloxacillin, and Lactobacillus Combined?

The general purpose of this combination is to neutralize susceptible bacterial infections while concurrently assisting in maintaining the natural balance of beneficial intestinal bacteria. The Amoxicillin/Cloxacillin pair works toward the killing or eradication of bacteria by interfering with the structural integrity of the bacterial cell wall. This potent anti-infective action is supported by the Lactobacillus component, which serves the primary function of assisting the restoration of good bacteria/Gut flora balance commonly disrupted during antibiotic therapy.

Advertisements

What side effects are possible with Amyclox LB?

Possible Side Effects and Safety Information

The safety profile for this combination medicine is primarily defined by the officially documented adverse reactions associated with the penicillin antibiotic class. The regulatory classification of effects indicates that the most common reactions reported in clinical studies include diarrhea, rash, nausea, and vomiting.

Adverse reactions are officially grouped by the organ systems affected, including Gastrointestinal Disorders (e.g., colitis, loose stools), Skin and Subcutaneous Tissue Disorders (e.g., urticaria, various rashes), Hepatobiliary Disorders (e.g., cholestatic hepatitis), and Hemic/Lymphatic Systems (e.g., transient anemias).

Serious Adverse Reactions and Safety Constraints

The official labeling documents the possibility of serious adverse reactions, despite their rare incidence. These include potentially fatal hypersensitivity reactions (anaphylaxis) and Severe Cutaneous Adverse Reactions (SCAR), such as Stevens-Johnson Syndrome (SJS). The documented risk also includes Clostridium difficile-associated diarrhea (CDAD), which can occur during or up to two months after treatment completion, and Drug-Induced Enterocolitis Syndrome (DIES).

Safety constraints noted in regulatory documents specify that use is restricted in individuals with a history of penicillin or cephalosporin hypersensitivity and is contraindicated in patients with infectious mononucleosis. Specific caution is formally advised for patients with renal or hepatic impairment, requiring periodic assessment during prolonged use. Furthermore, the risk of drug-resistant bacteria developing is a known safety limitation for all antibacterial agents.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

This section outlines the officially documented overdose profile for the antibiotic components of Amyclox LB, based on government regulatory labeling. The information describes the recognized manifestations and the mandatory actions required in case of suspected overdose.

Overdose Manifestations Severe Outcomes
Nausea, vomiting, and diarrhea Neurotoxicity (e.g., myoclonia, convulsive seizures)
Crystalluria (crystals in the urine) Risk of progression to coma and death
Decreased amount/frequency of urination Risk of congestive heart failure in renal impairment

Risk Factors and Required Actions

High concentrations of the antibiotic components are associated with potential central nervous system (CNS) effects. This risk is officially noted as being increased in patients with impaired renal function due to reduced drug elimination.

Required Emergency Actions:

  • Contact a Poison Control Center immediately for any suspected overdose.
  • Call emergency services (e.g., 911) immediately if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Management Notes

No specific antidote is formally documented in the regulatory labeling. Management is generally described as symptomatic and supportive. Amoxicillin is removed by hemodialysis. Maintaining adequate fluid intake and urinary output is advised to reduce the possibility of Amoxicillin-induced crystalluria.

Advertisements

Therapeutic Uses of Amyclox LB

What Amyclox LB Treats: Main Uses and Benefits

The primary purpose of Amyclox LB is to provide comprehensive support for patients dealing with conditions characterized by periods of heightened symptoms that are bacterial in origin. Its core component is widely utilized for infections of the ear, nose, throat, respiratory, and urinary tracts.

Treatment of Acute Symptomatic Infections

This medicine is commonly used across conditions presenting with acute episodes, such as severe respiratory tract infections, skin infections (e.g., cellulitis), and ear/throat infections (e.g., otitis media). This approach helps address symptom clusters that may appear suddenly and create noticeable discomfort, contributing to easing the overall symptom load.

Support Against Challenging Pathogens and Digestive Upset

The medicine is relevant in contexts involving heightened systemic burden, as its dual-component formulation is applied in addressing situations that require a broad anti-infective approach. The probiotic component is applied across domains where additional symptomatic support is needed, as it is relevant for easing gastrointestinal discomfort. This supports the management of digestive symptoms related to temporary physiological imbalance, which may assist with maintaining functional stability.

Quick Fact: Relief for Systemic Discomfort (The medication plays a role in managing symptoms that interfere with daily functioning, providing supportive relief when symptoms interfere with routine activities.)

Regulatory References

  1. NIH MedlinePlus overview of Amoxicillin
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Amyclox LB?

This section outlines the official population eligibility and non-eligibility status for Amyclox LB (Amoxicillin, Cloxacillin, Lactobacillus), strictly based on governmental regulatory documents.

Absolute Non-Eligibility

The medicine is contraindicated in patients with a known history of a serious hypersensitivity reaction (e.g., anaphylaxis) to Penicillins or any other β-Lactam antibacterial agents.

It is also contraindicated for individuals with a history of cholestatic jaundice or hepatic dysfunction associated with previous penicillin-class combination use.

Eligibility Restrictions and Cautions

Population Group Eligibility Status (Regulatory Wording)
Severe Renal Impairment Not recommended; use requires careful consideration and monitoring.
Infectious Mononucleosis Not recommended (should be avoided).
Hepatic Impairment Use requires caution and monitoring of liver function.
Preterm/Low-Weight Infants Not recommended due to risks associated with the live probiotic component.
Pregnancy/Lactation Generally compatible; use requires caution due to potential for infant sensitization.

Eligibility is generally established for Adult Patients and Pediatric Patients typically aged three months and older.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medication is a combination of two antibiotics and a probiotic, and its antibiotic components may interact with certain other medicines, medicinal product categories, or laboratory tests. You must inform your healthcare provider about all medicines you are taking, including over-the-counter products.

Interacting Product Category Specific Examples Potential Outcome / Constraint
Oral Contraceptives (Combined Hormonal) Explicitly listed as a risk May reduce the effectiveness of the contraceptive; use of non-hormonal barrier methods is often recommended.
Anticoagulants (Blood Thinners) Warfarin Increased risk of bleeding. Regular monitoring of blood coagulation markers (e.g., INR) is necessary.
Uricosuric Agents / Antigout Drugs Probenecid, Allopurinol Probenecid may increase and prolong the levels of the antibiotic components in the blood. Co-administration with Allopurinol may increase the risk of skin rash.
Antimetabolites (Chemotherapy) Methotrexate The antibiotic components may increase the levels and potential toxicity of Methotrexate.
Other Antibiotics Tetracyclines Certain other antibiotics may interfere with the bactericidal effect of the penicillin components.

Additionally, the antibiotic components may interfere with certain laboratory tests for urinary glucose (using cupric sulfate solutions like Benedict's solution or Clinitest®), potentially causing false-positive results. The use of the antibiotic is associated with a high incidence of rash in individuals with glandular fever (infectious mononucleosis).

Advertisements

Mechanism of Action

Amyclox LB operates through a triple-action pharmacodynamic mechanism. Component A, a beta-Lactamase inhibitor, competitively and irreversibly binds to the beta-lactamase enzyme. This interaction is mediated by the formation of a stable covalent bond at the enzyme's active site, preventing the enzyme's hydrolytic activity against Component B. Component B, the primary antibacterial agent, subsequently targets the bacterial cell wall synthesis pathway. It binds to and acylates transpeptidases, also known as penicillin-binding proteins (PBPs), inhibiting their enzymatic function. The resulting blockade of peptidoglycan cross-linking in the cell wall structure leads to a failure in structural integrity, ultimately resulting in osmotic instability and bacterial lysis. The non-systemic agent, LB (Lactobacillus Bacterium), introduces a specific bacterial species that colonizes the intestinal epithelium, thereby establishing a mechanism of competitive exclusion against other flora for limited adhesion sites and nutrients.

Advertisements

Dosage and Administration Information

How Amyclox LB Is Used

Amyclox LB, a fixed-dose oral combination product containing Amoxicillin, Cloxacillin, and Lactobacillus, is administered according to high-level principles established in prescribing information. The instructions detail the required dose timing, form handling, and duration of therapy, but not therapeutic outcomes or safety.

Official Dosing and Administration Parameters

Parameter Instruction Details
Route of Administration The approved and established route for all available forms (Capsule, Tablet, Suspension) is oral (by mouth).
Standard Frequency The medicine is taken in divided daily doses at fixed, equally spaced time intervals (e.g., every 8 or 12 hours) to maintain adequate drug levels.
Food Relationship May be taken with or without food. Taking it with food is generally acceptable and may help reduce the potential for gastrointestinal intolerance.
Dose Handling Solid forms (capsules, tablets) must be swallowed whole and should not be crushed or chewed. Liquid suspensions must be shaken well before measuring each dose.
Course Duration The entire prescribed course of treatment must be completed, even if the patient feels better, to ensure full elimination of susceptible bacteria.
Missed Dose If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is skipped. The dose must not be doubled.

Population-Specific Use Adjustments

Official labeling for the antibiotic components indicates that dose adjustments are necessary for patients with severe renal or hepatic impairment. For example, some regimens for the Cloxacillin component recommend a dose reduction of up to 50% when creatinine clearance falls below 30 mL/min. Pediatric dosing is typically calculated based on the patient’s body weight (mg/kg/day) rather than fixed adult doses.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Amyclox LB

Evidence on the Dual Anti-Infective Components

Research has examined this medicine's dual antibiotic components, Amoxicillin and Cloxacillin, primarily through systematic reviews of analogous fixed-dose combinations (FDCs) and retrospective data. Studies focused on outcomes related to systemic imbalance, such as monitoring physiological stress and markers of kidney function during short-term, high-dose use in severe infections. Comparative evidence is currently lacking to characterize the potential role of this specific FDC compared to research on standard single component therapies, leading to low certainty regarding its unique evidence base.

Evidence on the Supportive Probiotic Component

The supportive Lactobacillus-based probiotic was studied for its role in research exploring gastrointestinal outcomes during antibiotic therapy. The evidence is based on systematic reviews and meta-analyses of relevant Randomized Controlled Trials (RCTs) that report how symptoms evolved in the observed populations, mainly by monitoring the frequency of antibiotic-associated diarrhea (AAD). Pooled findings indicate that Lactobacillus administration was associated with differences in the rate of AAD across many trials. However, data are still emerging regarding the specific strain and dose ratio included in the Amyclox LB formulation.

Study Durations and Key Research Gaps

The majority of research conducted for both the anti-infective and supportive actions was studied for short, defined time intervals, with follow-up durations limited to monitoring the immediate measurements of patient status. There is limited information for long-term outcomes that would describe the sustained stability of the gut flora or the maintenance of clinical outcomes over an extended time. Furthermore, data for certain groups remain insufficient, with subgroup findings uncertain for pregnant individuals or those with severe, chronic gastrointestinal conditions. The research record describes what has been investigated—and what remains unclear—about this combination.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amyclox LB (FAQ)

Q: Is Amyclox LB safe for older adults (seniors)?

Official product information indicates that the use of Amyclox LB in older adults requires caution. This is primarily because dosing adjustments and careful monitoring of kidney function are often described as considerations, particularly for those with severe renal impairment.

Q: Are there any specific safety concerns about using Amyclox LB during pregnancy?

Official regulatory documents advise that use during pregnancy requires caution due to the potential for infant sensitization to the antibiotic components. The medicine is generally considered only after clinical assessment determines that the benefit outweighs the potential risk.

Q: Has Amyclox LB been studied in children?

The antibiotic components of Amyclox LB have established use in pediatric patients typically aged three months and older. The dose is typically calculated based on the patient’s body weight rather than using fixed adult doses.

Q: What are the signs of a non-serious allergic reaction to Amyclox LB?

The most common skin-related reactions listed in regulatory documents are rash and urticaria, also known as hives. Official warnings state that signs of severe allergic reactions (such as swelling of the face or throat, or trouble breathing) are classified as serious adverse events.

Q: Can Amyclox LB cause dark urine or changes in stool color?

Regulatory documents note that the medicine has been associated with adverse reactions that affect the liver and gallbladder (Hepatobiliary Disorders) and severe gastrointestinal issues. These types of complications may sometimes be associated with changes in the color of urine or stools.

Q: What is the typical duration of treatment with Amyclox LB?

The total duration of treatment is determined by the healthcare provider and is dependent on the specific infection being treated. For the antibiotic components, regulatory-aligned courses often range from 5 to 10 days for common infections, and completing the entire course is described as necessary for full elimination of susceptible bacteria.

Q: Why do doctors prescribe Amyclox LB instead of just Amoxicillin?

The combination includes the antibiotic Cloxacillin, which is intended to target certain bacterial strains that show resistance to standard penicillins like Amoxicillin alone. This combined approach is designed to provide a broader range of anti-infective activity.

Q: Are there long-term side effects associated with Amyclox LB use?

Official research evidence indicates that most studies on the components of this medicine are conducted over short, defined treatment periods. Consequently, there is limited information available in regulatory documents regarding long-term outcomes or sustained stability after extended use.

Q: Why do some people experience diarrhea while taking Amyclox LB?

Diarrhea is one of the most commonly reported side effects of the antibiotic components, as they can disrupt the natural balance of beneficial bacteria in the gut. The Lactobacillus component is included in the medicine to help with the restoration of the gut flora balance.

Q: How is Amyclox LB different from combination drugs like Augmentin?

Amyclox LB is a fixed-dose triple combination that integrates two penicillin-class antibiotics (Amoxicillin and Cloxacillin) with a probiotic component (Lactobacillus). In contrast, combination drugs like Augmentin contain Amoxicillin and a beta-lactamase inhibitor (Clavulanic Acid) but do not include a probiotic.

Q: Is the research evidence for Amyclox LB based on real-world or lab studies?

Official research supporting the use of the medicine’s components includes data from real-world clinical studies such as Randomized Controlled Trials (RCTs). Evidence is also drawn from systematic reviews of clinical trials, as well as laboratory-based (in-vitro) and retrospective data.

Q: What is the main difference between Amyclox LB and regular Amoxicillin?

The main difference is that Amyclox LB is a combination product that includes Cloxacillin (another penicillin-class antibiotic) and Lactobacillus (a probiotic), while Amoxicillin is a single active agent.

Q: How long does it usually take for Amyclox LB to start working?

According to pharmacokinetic studies, the main active components typically reach their maximum concentration in the bloodstream within one to two hours after a dose is taken by mouth. Individual response times, however, can vary depending on the patient and the infection.

Q: Are there any common foods or drinks that should be avoided when taking Amyclox LB?

Official product information indicates that the medicine may be taken with or without food. While no specific common foods are typically restricted, regulatory warnings indicate that alcohol intake is typically avoided or limited during the course of treatment.

Q: Will Amyclox LB affect my sleep?

Sleep effects are not listed as common side effects of the medicine. However, adverse reaction reports for the antibiotic components occasionally include central nervous system effects, such as dizziness or hyperactivity, which could indirectly affect a person's ability to sleep.

Q: Is there a generic version of Amyclox LB available?

Amyclox LB is the specific trade name for this fixed-dose triple combination product. While this specific trade name may not have a generic equivalent, similar combination medicines containing the same or related active components may be available under different product names.

Q: Is Amyclox LB known to cause dizziness or affect driving?

Dizziness is an officially documented possible side effect related to the antibiotic components of the medicine. Regulatory guidance states that caution is necessary if any side effects, such as dizziness, are experienced that could impair the ability to drive or operate machinery.

Q: How soon after stopping Amyclox LB can I consume alcohol?

Official product information primarily focuses on avoiding or limiting alcohol intake during the treatment course. Regulatory guidance generally suggests waiting until the entire prescribed course of medicine is completed and you have fully recovered from the infection before consuming alcohol.

Q: Does Amyclox LB affect blood sugar levels?

Regulatory documents indicate that the antibiotic components are known to interfere with certain laboratory tests used to check for glucose (sugar) in the urine, potentially causing false-positive results. The medicine is not generally reported to directly affect a person's blood sugar levels.

Q: What does the term 'broad-spectrum' mean when referring to Amyclox LB?

When referring to Amyclox LB, the term 'broad-spectrum' relates to the medicine's potential to be effective against a wide range of susceptible bacteria. This is achieved through the combination of its two penicillin-class antibiotic components.

Q: Are there different strengths of Amyclox LB available?

Regulatory documents list the commercially available dosage forms and specific approved strengths for the medicine. The appropriate strength and form are determined by a healthcare provider based on the condition being treated.

Q: Can Amyclox LB be used to prevent infections?

Official indications state that the medicine is approved for the treatment of infections caused by susceptible bacteria. Its use is generally limited to treating proven or strongly suspected bacterial infections and is not indicated for preventative use.

Q: What are the ingredients in Amyclox LB besides the main active compounds?

Regulatory product labels list the full composition, including the inactive ingredients (excipients) used in the formulation. These substances, such as coloring agents, fillers, and stabilizers, help create the final capsule, tablet, or suspension form.

Q: Is Amyclox LB often prescribed for ear infections?

The antibiotic components of the medicine are officially indicated for the treatment of susceptible infections in the ear, nose, and throat areas. This formal indication covers conditions such as bacterial ear infections (otitis media).

Q: Can Amyclox LB make me feel tired or fatigued?

While tiredness or fatigue are not listed as primary common side effects, regulatory documents on adverse reactions may include general complaints such as malaise. Persistent or severe fatigue is a symptom that should be noted for the prescribing healthcare professional.

Advertisements

How should Amyclox LB be stored and disposed of?

How to Store and Dispose of Amyclox LB?

This section outlines the official, label-based requirements for the storage, handling, and disposal of Amyclox LB, as defined by government regulatory documents.


Official Storage Requirements

Storage Factor Regulatory Mandate
Temperature Store at or below 30°C (86°F). Avoid exposure to excessive heat.
Protection Must be kept in a dry place and protected from light and moisture.
Packaging Keep the medicine sealed in its original container with the lid or seal tightly closed.
Child Safety Keep out of the sight and reach of children at all times.

Handling and Disposal

The required storage conditions are critical for maintaining the chemical stability of the antibiotics (Amoxicillin, Cloxacillin) and the viability of the Lactobacillus probiotic component.

For disposal, unused or expired Amyclox LB must not be thrown into household trash or poured down a sink/toilet. The medicine should be returned to an authorized drug take-back program or disposed of according to specific local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amyclox LB found in:

A-Z Index: